Indication
Ajovy is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.
Loading your page…
Loading your page…
Migraine Disorders
Marketing Authorisation Holder: Teva GmbH
EMA Authorisation: 28/03/2019
INN: fremanezumab
AI Drug & Interaction Analysis
Free account required
Ask Osler about Ajovy: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.